Did you know?
ChinaBio® LLC is a consulting and advisory firm that helps Western companies come to China. We assist our clients with China strategy development, market research and analysis, partner/technology searches, competitive surveys, and market entry planning.

>> Learn more…
Site Search

>> Advanced Search

  Quick Search:
 
 

Free Newsletter

  Email address:
   

China Medicine Registers Vascular Drug in Pakistan

publication date: Oct 20, 2009
View a Printer Friendly version of this page, allowing you to print the page. Send a summary of this page to someone via email.

China Medicine Corporation announced that Levocarnitine Dried Powder Injection has been registered in Pakistan. Levocarnitine is used to treat coronary heart disease and acute myocardial infarction. For China Medicine, the event is significant because it is the company’s first sales foray outside the PRC. More details...

Stock Symbol: (OTCBB: CHME)




Sorry... this feature or article is only available to subscribers.

>> Learn more about our subscription plans...

>> Free email newsletter...

>> Login...

Login

  

    
   
Partner Events

China Medical Affairs Summit
June 12-13, 2014
Shanghai, China


>>More events...
Our Partners
Annual Sponsors
 
Official Partners
 
Supporting Partners
 
Media Partners